PAB 28.6% 2.7¢ patrys limited

Company to resolve

  1. 595 Posts.
    As a result it is unlikely that the next clinical trial will commence in the second quarter as planned. Patrys is working to have the issues resolved quickly, but until further investigation is complete it cannot make a definitive statement as to the exact timing of the commencement of its next trial. While this delay is extremely disappointing these events are not uncommon in the manufacturing of biologicals.
    Come on people the company states it's next trial will be soon, not all is lost .
watchlist Created with Sketch. Add PAB (ASX) to my watchlist
(20min delay)
Mkt cap ! $22.52M
Open High Low Value Volume
2.1¢ 2.7¢ 2.1¢ $277.6K 11.99M

Buyers (Bids)

No. Vol. Price($)
2 281185 2.6¢

Sellers (Offers)

Price($) Vol. No.
2.7¢ 698486 3
View Market Depth
Last update - 14.23pm 20/03/2019 (20 minute delay) ?
0.006 ( 23.8 %)
Open High Low Volume
2.2¢ 2.7¢ 2.2¢ 5440963
Last updated 14.42pm 20/03/2019 (live) ?
PAB (ASX) Chart
GET SUPPORT arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.